132122-28-2 Usage
Derivative of pyrrole
This compound is based on a pyrrole ring, which is a five-membered ring with one nitrogen atom.
Contains a carboxylic acid and formyl functional groups
The carboxylic acid group (-COOH) and formyl group (-CHO) are both functional groups present in this compound, giving it specific chemical properties.
Used in organic synthesis and pharmaceutical research
This compound may be used as a building block or reagent in the synthesis of other complex molecules, including potential drug candidates.
Potential applications in the development of new drugs
The exact uses and properties of this compound may depend on the specific application, but it may have potential in the development of new drugs.
Properties and uses may vary depending on the specific application
The properties and uses of this compound may differ depending on the specific application or context in which it is used.
Check Digit Verification of cas no
The CAS Registry Mumber 132122-28-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,1,2 and 2 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 132122-28:
(8*1)+(7*3)+(6*2)+(5*1)+(4*2)+(3*2)+(2*2)+(1*8)=72
72 % 10 = 2
So 132122-28-2 is a valid CAS Registry Number.
132122-28-2Relevant articles and documents
PYRROLE mTORC INHIBITORS AND USES THEREOF
-
Paragraph 0730, (2020/01/12)
The present invention provides compounds, compositions thereof, and methods of using the same.
OLEFIN SUBSTITUTED OXINDOLES HAVING AMPK ACTIVITY
-
Page/Page column 74, (2015/01/07)
The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
